We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-11.53%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$361M
AUM Growth
+$175M
Cap. Flow
-$29.7M
Cap. Flow %
-8.24%
Top 10 Hldgs %
90.77%
Holding
111
New
18
Increased
19
Reduced
27
Closed
38

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$5.25M
2
TRAW icon
Traws Pharma
TRAW
+$3.96M
3
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
+$1.9M
4
BPTH
Bio-Path Holdings Inc
BPTH
+$1.16M
5
TOPS icon
TOP Ships
TOPS
+$1.13M

Top Sells

Rank Stock Value
1
TEUM
Pareteum Corporation
TEUM
+$2.9M
2
RDGT
Ridgetech Inc
RDGT
+$1.59M
3
CRMD icon
CorMedix
CRMD
+$1.59M
4
ARCT icon
Arcturus Therapeutics
ARCT
+$1.28M
5
ATNM icon
Actinium Pharmaceuticals
ATNM
+$1.27M

Sector Composition

Rank Sector Weight
1 Healthcare 5.35%
2 Industrials 0.18%
3 Technology 0.07%
4 Consumer Discretionary 0.01%
5 Materials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRMD icon
76
CorMedix
CRMD
$577M
– –
-249,198
Closed -$1.59M
CRMD icon
77
PUT
CorMedix
CRMD
$577M
– –
-1,936
Closed -$1.24M
CTXR icon
78
Citius Pharmaceuticals
CTXR
$13.7M
– –
-33,817
Closed -$640K
HYPD
79
Hyperion DeFi Inc
HYPD
$36.7M
– –
-224
Closed -$66K
HEPA
80
DELISTED
Hepion Pharmaceuticals
HEPA
– –
-115
Closed -$278K
IMNN icon
81
CALL
Imunon
IMNN
$6.43M
– –
-1
Closed -$40K
OEF icon
82
PUT
iShares S&P 100 ETF
OEF
$19.8B
– –
-1,578
Closed -$23.9M
OPTT icon
83
Ocean Power Technologies
OPTT
$40.6M
– –
-150,000
Closed -$269K
ORMP icon
84
CALL
Oramed Pharmaceuticals
ORMP
$171M
– –
-1,120
Closed -$357K
ORMP icon
85
Oramed Pharmaceuticals
ORMP
$171M
– –
-185,800
Closed -$696K
RKDA icon
86
Arcadia Biosciences
RKDA
$1.37M
– –
-1,251
Closed -$234K
TTNP
87
DELISTED
Titan Pharmaceuticals
TTNP
– –
-139
Closed -$22K
TTNP
88
PUT
DELISTED
Titan Pharmaceuticals
TTNP
– –
0
– -$3K
VXRT
89
DELISTED
Vaxart
VXRT
– –
-1,197,710
Closed -$430K
XTIA icon
90
XTI Aerospace
XTIA
$57.3M
– –
0
– -$275K
RNTX
91
Rein Therapeutics
RNTX
$66.9M
– –
-27,495
Closed -$368K
RDGT
92
Ridgetech Inc
RDGT
$1.04M
– –
-37
Closed -$1.59M
SEEL
93
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
-128
Closed -$451K
VBIV
94
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
– –
-29,205
Closed -$413K
SOLO
95
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
– –
-288,408
Closed -$587K
DMK
96
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
– –
-2,619
Closed -$127K
BLCM
97
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-4,201
Closed -$44K
TMDI
98
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
– –
-41,085
Closed -$44K
ADXS
99
DELISTED
Advaxis Inc
ADXS
– –
-1,521,982
Closed -$403K
KDMN
100
PUT
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-114
Closed -$321K
1 2 3
4
5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q4 2019 Portfolio in Review

As of Q4 2019, Sabby Management held 111 positions worth $361M, up 94% from $186M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Sabby Management withdrew a net $29.7M in Q4 2019, closing 38 positions and reducing 27 holdings. Its most notable exit was Pareteum Corporation, an estimated $2.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, down from 15% a quarter earlier, followed by Industrials and Technology.

Against the trend, Sabby Management opened a new position in SPDR Gold Trust worth $5.37M.

  • Sabby Management's largest Q4 2019 buy was SPDR Gold Trust: 37,550 shares worth $5.37M.
  • Sabby Management added most to Traws Pharma in Q4 2019, an estimated $3.96M increase.
  • Sabby Management's biggest Q4 2019 reduction was Actinium Pharmaceuticals, cutting an estimated $1.27M.
  • Sabby Management fully exited Pareteum Corporation in Q4 2019, selling an estimated $2.9M.
  • Sabby Management's ten largest holdings make up 91% of its $361M portfolio in Q4 2019.
  • Sabby Management opened 18 new positions and closed 38 in Q4 2019.
  • Sabby Management's portfolio value rose 94% quarter-over-quarter to $361M.

Based on Sabby Management's 13F filing for Q4 2019, filed 14 Feb 2020.